{"title":"ChatGPT: how to use it and the pitfalls/cautions in academia.","authors":"Jeong-Moo Lee","doi":"10.6065/apem.2550028.014","DOIUrl":null,"url":null,"abstract":"<p><p>The integration of large language models (LLMs) in academic research has transformed traditional research methodologies. This review investigates the current state, applications, and limitations of LLMs, particularly ChatGPT, in medical and scientific research. I performed a systematic review of recent literature and LLM development reports in artificial intelligence-assisted research tools, including commercial LLM services (GPT-4o, Claude 3, Gemini Pro) and specialized research platforms (Genspark, Scispace). I evaluated their performance, applications, and limitations across stages of the research process. Recent advancements in LLMs shows potential for improving research efficiency, particularly in literature review, data analysis, and manuscript preparation. Performance comparison revealed varying strengths: GPT-4o and o1 outperformed in the overall area, Claude 3 in writing and coding, and Gemini Pro in multimodal processing. Therefore, it is important to choose and use each model wisely according to its advantages. However, hallucination risks, inherent biases, plagiarism concerns, and privacy issues are concerns in LLMs. The emergence of Retrieval-Augmented Generation models and specialized research tools has improved accuracy and current information access. LLMs offer effective support for research productivity, but they should serve as complementary tools rather than primary research drivers. The successful application of these tools depends on a thorough understanding of their limitations, strict adherence to ethical guidelines, and preservation of researcher autonomy.</p>","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"30 5","pages":"229-241"},"PeriodicalIF":2.4000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12597148/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Pediatric Endocrinology & Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6065/apem.2550028.014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
The integration of large language models (LLMs) in academic research has transformed traditional research methodologies. This review investigates the current state, applications, and limitations of LLMs, particularly ChatGPT, in medical and scientific research. I performed a systematic review of recent literature and LLM development reports in artificial intelligence-assisted research tools, including commercial LLM services (GPT-4o, Claude 3, Gemini Pro) and specialized research platforms (Genspark, Scispace). I evaluated their performance, applications, and limitations across stages of the research process. Recent advancements in LLMs shows potential for improving research efficiency, particularly in literature review, data analysis, and manuscript preparation. Performance comparison revealed varying strengths: GPT-4o and o1 outperformed in the overall area, Claude 3 in writing and coding, and Gemini Pro in multimodal processing. Therefore, it is important to choose and use each model wisely according to its advantages. However, hallucination risks, inherent biases, plagiarism concerns, and privacy issues are concerns in LLMs. The emergence of Retrieval-Augmented Generation models and specialized research tools has improved accuracy and current information access. LLMs offer effective support for research productivity, but they should serve as complementary tools rather than primary research drivers. The successful application of these tools depends on a thorough understanding of their limitations, strict adherence to ethical guidelines, and preservation of researcher autonomy.
期刊介绍:
The Annals of Pediatric Endocrinology & Metabolism Journal is the official publication of the Korean Society of Pediatric Endocrinology. Its formal abbreviated title is “Ann Pediatr Endocrinol Metab”. It is a peer-reviewed open access journal of medicine published in English. The journal was launched in 1996 under the title of ‘Journal of Korean Society of Pediatric Endocrinology’ until 2011 (pISSN 1226-2242). Since 2012, the title is now changed to ‘Annals of Pediatric Endocrinology & Metabolism’. The Journal is published four times per year on the last day of March, June, September, and December. It is widely distributed for free to members of the Korean Society of Pediatric Endocrinology, medical schools, libraries, and academic institutions. The journal is indexed/tracked/covered by web sites of PubMed Central, PubMed, Emerging Sources Citation Index (ESCI), Scopus, EBSCO, EMBASE, KoreaMed, KoMCI, KCI, Science Central, DOI/CrossRef, Directory of Open Access Journals(DOAJ), and Google Scholar. The aims of Annals of Pediatric Endocrinology & Metabolism are to contribute to the advancements in the fields of pediatric endocrinology & metabolism through the scientific reviews and interchange of all of pediatric endocrinology and metabolism. It aims to reflect the latest clinical, translational, and basic research trends from worldwide valuable achievements. In addition, genome research, epidemiology, public education and clinical practice guidelines in each country are welcomed for publication. The Journal particularly focuses on research conducted with Asian-Pacific children whose genetic and environmental backgrounds are different from those of the Western. Area of specific interest include the following : Growth, puberty, glucose metabolism including diabetes mellitus, obesity, nutrition, disorders of sexual development, pituitary, thyroid, parathyroid, adrenal cortex, bone or other endocrine and metabolic disorders from infancy through adolescence.